Ex-P&G Beauty CEO Alex Keith set to join Diageo (NYSE: DEO) board
Rhea-AI Filing Summary
Diageo plc reports the planned appointment of R. Alexandra (Alex) Keith as a Non-Executive Director. The appointment is effective 5 November 2026, subject to shareholder approval at the Annual General Meeting. She will also join the Board’s Remuneration and Nomination Committees from that date.
Alex Keith brings more than 35 years of international consumer goods experience and most recently served as Chief Executive Officer of Procter & Gamble’s Beauty business, where she led a major global beauty portfolio. She has held leadership roles across North America, Europe and Asia, and since 2020 has been a non-executive director of Thermo Fisher Scientific Inc. Diageo’s Chair, Sir John Manzoni, highlights her recent CEO experience in consumer goods and her role in transforming and shaping branded portfolios to respond to consumer trends.
Positive
- None.
Negative
- None.
Key Figures
Effective appointment date: 5 November 2026
Industry experience: more than 35 years
Thermo Fisher directorship start: 2020
+3 more
6 metrics
Effective appointment date
5 November 2026
Date Alex Keith is expected to join the Board, subject to shareholder approval
Industry experience
more than 35 years
Alex Keith’s international consumer goods experience
Thermo Fisher directorship start
2020
Year Alex Keith began serving as a non-executive director of Thermo Fisher Scientific Inc.
Countries where products are sold
nearly 180 countries
Global reach of Diageo’s beverage alcohol brands
Form type
Form 6-K
Report of foreign private issuer under the Securities Exchange Act of 1934
Date of report
18 August 2026
Date on which Diageo recorded this report and announcement
Key Terms
Form 6-K, foreign private issuer, Non-Executive Director, Remuneration Committee, +2 more
6 terms
Form 6-K regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER"
A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.
foreign private issuer regulatory
"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Non-Executive Director financial
"appointment of R. Alexandra ("Alex") Keith as a Non-Executive Director"
A non-executive director is a member of a company’s board who does not work for the company day-to-day but provides independent oversight, strategic guidance and checks on management. For investors, they matter because they act like an impartial referee or outside advisor, helping ensure decisions protect shareholder interests, reduce risks of poor governance, and add credibility to financial reporting and long-term strategy.
Remuneration Committee financial
"will become a member of the Board's Remuneration and Nomination Committees"
A remuneration committee is a group of independent board members who design, approve and oversee pay packages for a company’s executives and directors. Think of them as the household budget planners for top management: they decide salaries, bonuses and stock awards so pay rewards performance and limits excessive risk. For investors, their role matters because compensation policies affect management incentives, business strategy and the long‑term value shareholders receive.
Nomination Committee financial
"member of the Board's Remuneration and Nomination Committees"
A nomination committee is a small group of board members that screens, selects and recommends people to serve on a company’s board of directors and oversees succession planning for top executives. Think of it as a hiring panel for the board that checks skills, independence and fit so the leadership mix supports the company’s goals. Investors care because the committee shapes who sets strategy, manages risk and protects shareholder interests.
Listing Rule 6.4.8 regulatory
"no further details to be disclosed pursuant to Listing Rule 6.4.8"
FAQ
What board change did Diageo (DEO) announce in this Form 6-K?
Diageo announced the planned appointment of R. Alexandra (Alex) Keith as a Non-Executive Director on its Board, effective 5 November 2026, subject to shareholder approval at the company’s Annual General Meeting.
When will Alex Keith join the Diageo (DEO) Board and its committees?
Alex Keith is expected to join the Diageo Board on 5 November 2026, subject to shareholder approval, and will simultaneously become a member of the Board’s Remuneration Committee and Nomination Committee from the same date.
What is Alex Keith’s professional background relevant to Diageo (DEO)?
Alex Keith has over 35 years of international consumer goods experience and most recently served as CEO of Procter & Gamble’s Beauty business, leading a major global beauty portfolio focused on innovation, portfolio development and organizational transformation.
What other board role does Alex Keith currently hold alongside Diageo (DEO)?
Since 2020, Alex Keith has served as a non-executive director of Thermo Fisher Scientific Inc., a US-based life sciences company, bringing additional board-level experience in a large, diversified global business to her new role at Diageo.
How does Diageo (DEO) describe its global presence in this report?
Diageo describes itself as a global leader in beverage alcohol with brands such as Johnnie Walker, Smirnoff, Baileys and Guinness, and states that its products are sold in nearly 180 countries around the world.
AI-generated analysis. How Rhea-AI works. Not financial advice.
